Therapeutic use of new biomaterial base on the nanotechnology for the treatment of chronic wounds
Project/Area Number |
17K11546
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Plastic surgery
|
Research Institution | Saitama Medical University |
Principal Investigator |
|
Project Period (FY) |
2017-04-01 – 2020-03-31
|
Project Status |
Completed (Fiscal Year 2019)
|
Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
Keywords | 創傷治癒 / 創傷 |
Outline of Final Research Achievements |
Three major components of regenerative medicine include cell, signal molecule and scaffold. This study aims at developing comprehensive wound management system integrating regenerative biotechnology and physical therapy. Thus far, we have estimated the efficacy of our original biomaterial in vivo.
|
Academic Significance and Societal Importance of the Research Achievements |
再生医療の分野は、創傷治癒でも有用な手段となりつつある。形成外科医は、臨床の場で人工真皮という足場を用いて、創傷治療を行なっている。既存の足場のみならず我々は、ポリグリコール酸を使用したナノファイバーの足場(PGA/collagen)を開発し、その有効性を示した。
|
Report
(4 results)
Research Products
(13 results)